This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Trypanosomiasis, African, Sleeping Sickness or Trypanosomiasis; Gambian
and you are
over 6
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study evaluates the effectiveness of fexinidazole administered to patients with g-HAT at all stages of the disease. The aim of the present study is to provide additional information on the effectiveness and safety of fexinidazole and to assess its use under conditions as close as possible to those in real life, both in patients treated on an out-patient basis and in the hospital setting, depending on clinical status

Provided treatments

  • Drug: Fexinidazole

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03025789. The sponsor of the trial is Drugs for Neglected Diseases and it is looking for 174 volunteers for the current phase.
Official trial title:
An Open-label Study Assessing Effectiveness, Safety and Compliance With Fexinidazole in Patients With Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage